Income Tax Expense (Benefit) of MARINUS PHARMACEUTICALS, INC. from 30 Sep 2022 to 31 Dec 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: MARINUS PHARMACEUTICALS, INC. annual and quarterly Income Tax Expense (Benefit) in USD history and change rate from 30 Sep 2022 to 31 Dec 2023.
MARINUS PHARMACEUTICALS, INC. Income Tax Expense (Benefit) for the quarter ending 30 Jun 2023 was $1,538,000.
MARINUS PHARMACEUTICALS, INC. annual Income Tax Expense (Benefit) for 2023 was $1,538,000, a 145% decline from 2022.
Source SEC data: View on sec.gov

Income Tax Expense (Benefit), Annual (USD)

Income Tax Expense (Benefit), YoY Annual Change (%)

Income Tax Expense (Benefit), Quarterly (USD)

MARINUS PHARMACEUTICALS, INC. Annual Income Tax Expense (Benefit) (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2023	$1,538,000	-$4,927,000	-145%	01 Jan 2023	31 Dec 2023	10-K	05 Mar 2024	2023	FY
2022	$3,389,000			01 Jan 2022	31 Dec 2022	10-K	05 Mar 2024	2023	FY

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2023		$1,538,000			01 Apr 2023	30 Jun 2023	10-Q	13 Aug 2024	2024	Q2
Q3 2022		$1,752,000			01 Jul 2022	30 Sep 2022	10-Q	07 Nov 2023	2023	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.